Literature DB >> 4825624

Urinary iron excretion in thalassaemia after desferrioxamine administration.

R Seshadri, J H Colebatch, R Fisher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4825624      PMCID： PMC1648673          DOI： 10.1136/adc.49.3.195

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  15 in total

1.  Measurement of iron stores using deferoxamine.

Authors:  S P Balcerzak; M P Westerman; E W Heinle; F H Taylor
Journal:  Ann Intern Med       Date:  1968-03       Impact factor: 25.391

2.  Desferrioxamine in thalassaemia.

Authors:  M Diwany; M Gabr; A el Hefni; N Mokhtar
Journal:  Arch Dis Child       Date:  1968-06       Impact factor: 3.791

3.  Storage iron and desferrioxamine.

Authors:  J Fielding
Journal:  Proc R Soc Med       Date:  1970-12

4.  A new method for serum iron and total iron-binding capacity by atomic absorption spectrophotometry.

Authors:  A D Olson; W B Hamlin
Journal:  Clin Chem       Date:  1969-06       Impact factor: 8.327

5.  Clinical and laboratory studies on the action of desferrioxamine.

Authors:  R L Cumming; J A Millar; J A Smith; A Goldberg
Journal:  Br J Haematol       Date:  1969-09       Impact factor: 6.998

6.  Application of atomic absorption spectrophotometry in the determination of iron in urine.

Authors:  A Zettner; L Mansbach
Journal:  Am J Clin Pathol       Date:  1965-11       Impact factor: 2.493

7.  Iron excretion in thalassemia after the administration of chelating agents.

Authors:  A H Markum; W Iskandar; K L Keng; O Odang
Journal:  Paediatr Indones       Date:  1969 May-Jun

8.  Sideruria following a single dose of desferrioxamine-B as a diagnostic test in iron overload.

Authors:  J E Ploem; J de Wael; M C Verloop; K Punt
Journal:  Br J Haematol       Date:  1966-07       Impact factor: 6.998

9.  Desferrioxamine chelatable iron in haemolytic, megaloblastic and sideroblastic anaemias.

Authors:  C D Karabus; J Fielding
Journal:  Br J Haematol       Date:  1967-11       Impact factor: 6.998

10.  Deferoxamine and diethylenetriaminepentaacetic acid (DTPA) in thalassemia.

Authors:  R McDonald
Journal:  J Pediatr       Date:  1966-10       Impact factor: 4.406
View more
  2 in total

1.  Long-term administration of desferrioxamine in thalassaemia major.

Authors:  R Seshadri; J H Colebatch; P Gordon; H Ekert
Journal:  Arch Dis Child       Date:  1974-08       Impact factor: 3.791

2.  TLc-A, the leading nanochelating-based nanochelator, reduces iron overload in vitro and in vivo.

Authors:  Somayeh Kalanaky; Maryam Hafizi; Sepideh Safari; Kazem Mousavizadeh; Mahboubeh Kabiri; Alireza Farsinejad; Saideh Fakharzadeh; Mohammad Hassan Nazaran
Journal:  Int J Hematol       Date:  2016-02-01       Impact factor: 2.490
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.